| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |